Flexion Therapeutics

$12.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.08%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell FLXN and other stocks, options, and ETFs commission-free!

About FLXN

Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. The listed name for FLXN is Flexion Therapeutics, Inc. Common Stock.

CEO

Michael D. Clayman

Employees

288

Headquarters

Burlington, Massachusetts

Founded

2015

Market Cap

569.63M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

744.70K

High Today

$13.19

Low Today

$11.80

Open Price

$11.95

Volume

1.16M

52 Week High

$18.87

52 Week Low

$5.01

Collections

Analyst Ratings

92%

of 12 ratings

Buy

92%

Hold

Sell

FLXN Earnings

-$1.05

-$0.70

-$0.35

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, After Hours